Bruderman Asset Management, LLC Eli Lilly & CO Transaction History

Bruderman Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $58,829 - $68,668	-531 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $222 - $262	2 Added 0.38%	531 $69,000
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $52,420 - $58,726	495 Added 1455.88%	529 $61,000
Q2 2018 Aug 15, 2018	BUY	$75.7 - $86.88 $75 - $86	1 Added 3.03%	34 $3,000
Q1 2018 May 10, 2018	BUY	$74.21 - $87.6 $2,448 - $2,890	33 New	33 $3,000

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $743B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Bruderman Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bruderman Asset Management, LLC with notifications on news.